Thomas Kahan

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Verksam som överläkare vid Hjärtkliniken, Danderyds sjukhus.
Läkarutbildning på Karolinska Institutet. Disputerad i farmakologi. Docent
i farmakologi och invärtesmedicin. Professor i medicin. Specialist i
invärtesmedicin och kardiologi
verksam som klinisk kardiolog.

Forskningsbeskrivning

Huvudintresse är neurohormonella reglerlekanismer för kontroll av blodtryck
och hjärtfunktion med fokus på strukturella förändringar av blodkärl vid
till hypertoni, hypertensiv hjärsjukdom, neuroendokrina reglermekanismer vid
hjärtsivkt och hur hypertoni kan leda till kronisk hjärtsvikt. Det
sympatiska nervsystemet och renin-angiotensin-aldosteronsystemet är av
särskilt intresse. Andra forskningsområden är kardiovaskulär
riskvärdering och kardiovaskulär prevention samt hälsoekonomi och
implementering av befintlig kunskap i klinisk sjukvård.

Artiklar

Article: BMJ OPEN QUALITY. 2024;13(1):e002475

Lack of associations between hospital rating and outcomes in patients with an acute coronary syndrome.

Aspberg S; Kahan T; Johansson F
Article: CLINICAL KIDNEY JOURNAL. 2024;17(3):sfae050

Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function.

Salzinger B; Lundwall K; Evans M; Mörtberg J; Wallén H; Jernberg T; Kahan T; Lundman P; Tornvall P; Erlinge D; Lindahl B; Baron T; Rezeli M; Spaak J; Jacobson SH
Article: AMERICAN HEART JOURNAL. 2024;269:118-130

Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention.

Mazhar F; Hjemdahl P; Sjölander A; Kahan T; Jernberg T; Carrero JJ
Article: HYPERTENSION RESEARCH. 2024;47(2):435-444

Blood pressure in atrial fibrillation and in sinus rhythm during ambulatory blood pressure monitoring: data from the TEMPLAR project.

Lundwall K; Kahan T; Omboni S
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2024;11:1350726

Estimation of aortic stiffness by finger photoplethysmography using enhanced pulse wave analysis and machine learning.

Hellqvist H; Karlsson M; Hoffman J; Kahan T; Spaak J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2023;:zwad389

Long-term secondary prevention and outcome following acute coronary syndrome: Real-world results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Bentzel S; Ljungman C; Hjerpe P; Schiöler L; Manhem K; Bengtsson Boström K; Kahan T; Mourtzinis G
Article: RESUSCITATION. 2023;193:109978

Rapid response team activation prior to in-hospital cardiac arrest: Areas for improvements based on a national cohort study.

Thorén A; Jonsson M; Spångfors M; Joelsson-Alm E; Jakobsson J; Rawshani A; Kahan T; Engdahl J; Jadenius A; Boberg von Platen E; Herlitz J; Djärv T
Article: EUROPEAN HEART JOURNAL. 2023;44(15):1313-1330

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Barbato E; Azizi M; Schmieder RE; Lauder L; Böhm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Lüscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
Article: JOURNAL OF HYPERTENSION. 2023;41(4):527-544

Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗.

Parati G; Bilo G; Kollias A; Pengo M; Ochoa JE; Castiglioni P; Stergiou GS; Mancia G; Asayama K; Asmar R; Avolio A; Caiani EG; De La Sierra A; Dolan E; Grillo A; Guzik P; Hoshide S; Head GA; Imai Y; Juhanoja E; Kahan T; Kario K; Kotsis V; Kreutz R; Kyriakoulis KG; Li Y; Manios E; Mihailidou AS; Modesti PA; Omboni S; Palatini P; Persu A; Protogerou AD; Saladini F; Salvi P; Sarafidis P; Torlasco C; Veglio F; Vlachopoulos C; Zhang Y
Article: EUROINTERVENTION. 2023;18(15):1227-1243

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Barbato E; Azizi M; Schmieder RE; Lauder L; Böhm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Lüscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;373:64-71

Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.

Mörtberg J; Salzinger B; Lundwall K; Edfors R; Jacobson SH; Wallén HN; Jernberg T; Baron T; Erlinge D; Andell P; James S; Eggers KM; Hjort M; Kahan T; Lundman P; Tornvall P; Rezeli M; Marko-Varga G; Lindahl B; Spaak J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2023;30(1):48-60

New perspectives for hypertension management: progress in methodological and technological developments.

Parati G; Goncalves A; Soergel D; Bruno RM; Caiani EG; Gerdts E; Mahfoud F; Mantovani L; McManus RJ; Santalucia P; Kahan T
Article: PATIENT PREFERENCE AND ADHERENCE. 2023;17:3331-3339

A Qualitative Study on Patients' Views on Hypertension and Antihypertensive Medications.

Malkon S; Wettermark B; Kahan T; Bastholm-Rahmner P; Hasselström J; Qvarnström M
Article: BLOOD PRESSURE. 2022;31(1):71-79

Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension.

Weber T; Amar J; de Backer T; Burkard T; van der Giet M; Gosse P; Januszewicz A; Kahan T; Mancia G; Mayer CC; Muiesan ML; Stergiou GS; Tsioufis K; Vaisse B; Kreutz R; Covid-19 Task Force of the European Society of Hyp
Article: BLOOD PRESSURE. 2022;31(1):91-99

Aortic stiffness and aortic-brachial stiffness mismatch as markers of renal dysfunction in hypertension.

Lundwall K; Jekell A; Desta L; Jacobson SH; Kahan T; Spaak J
Article: EUROPEAN HEART JOURNAL. 2022;43(46):4777-4788

Sex differences in arterial hypertension.

Gerdts E; Sudano I; Brouwers S; Borghi C; Bruno RM; Ceconi C; Cornelissen V; Diévart F; Ferrini M; Kahan T; Løchen M-L; Maas AHEM; Mahfoud F; Mihailidou AS; Moholdt T; Parati G; de Simone G
Article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2022;32(12):2803-2810

Prediabetes and incident heart failure in hypertensive patients: Results from the Swedish Primary Care Cardiovascular Database.

Johansson JSM; Boström KB; Hjerpe P; Mourtzinis G; Kahan T; Ljungman C
Article: HEALTH EXPECTATIONS. 2022;25(6):3053-3061

User experience of self-reported computerized medical history taking for acute chest pain: The Clinical Expert Operating System Chest Pain Danderyd Study.

Sundberg K; Adeli A; Brandberg H; Spaak J; Koch S; Sundberg CJ; Zakim D; Kahan T; Fritzell K
Article: HYPERTENSION RESEARCH. 2022;45(9):1486-1495

24-hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project.

Omboni S; Ballatore T; Rizzi F; Tomassini F; Campolo L; Panzeri E; Lundwall K; Kahan T
Article: RESUSCITATION PLUS. 2022;9:100191

The predictive power of the National Early Warning Score (NEWS) 2, as compared to NEWS, among patients assessed by a Rapid response team: A prospective multi-centre trial.

Thorén A; Joelsson-Alm E; Spångfors M; Rawshani A; Kahan T; Engdahl J; Jonsson M; Djärv T
Article: MICROCIRCULATION. 2022;29(2):e12747

Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non-diabetic hypertensive patients.

Jekell A; Kalani M; Kahan T
Article: ATHEROSCLEROSIS. 2021;338:55-63

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement.

Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgözoğlu L
Article: HYPERTENSION. 2021;78(5):1241-1247

Heart Failure Events in a Clinical Trial on Arterial Hypertension: New Insights Into the SPRINT Trial.

Sobieraj P; Nilsson PM; Kahan T
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2021;39(4):519-526

Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database.

Mourtzinis G; Manhem K; Kahan T; Schiöler L; Isufi J; Ljungman C; Andersson T; Hjerpe P
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2021;78(4):551-559

Altered Vascular Reactivity to Circulating Angiotensin II in Familial Hypercholesterolemia.

Ekholm M; Wallén HN; Brinck J; Jörneskog G; Kahan T
Article: EUROPEAN HEART JOURNAL OPEN. 2021;1(1):oeab021

Open Up your Science in EHJ Open.

Bäck M; Banach M; Braunschweig F; De Rosa S; Gimelli A; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Nagy E; Savarese G; Szummer K; Wahl D; European Heart Journal Open Section Editors
Article: JOURNAL OF HYPERTENSION. 2021;39(8):1522-1545

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension.

Kasiakogias A; Rosei EA; Camafort M; Ehret G; Faconti L; Ferreira JP; Brguljan J; Januszewicz A; Kahan T; Manolis A; Tsioufis K; Weber T; von Lueder TG; Smiseth OA; Wachtell K; Kjeldsen SE; Zannad F; Mancia G; Kreutz R
Article: JOURNAL OF HYPERTENSION. 2021;39(8):1670-1677

Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and oral anticoagulants: results from The Swedish Primary Care Cardiovascular Database of Skaraborg.

Bager J-E; Hjerpe P; Schiöler L; Bengtsson Boström K; Kahan T; Ödesjö H; Jood K; Hasselström J; Ljungman C; Manhem K; Mourtzinis G
Article: JOURNAL OF HYPERTENSION. 2021;39(6):1155-1162

Country of birth and mortality risk in hypertension with and without diabetes: the Swedish primary care cardiovascular database.

Andersson T; Pikkemaat M; Schiöler L; Hjerpe P; Carlsson AC; Wändell P; Manhem K; Kahan T; Bengtsson Boström K
Article: JOURNAL OF MEDICAL INTERNET RESEARCH. 2021;23(4):e25493

Use of Self-Reported Computerized Medical History Taking for Acute Chest Pain in the Emergency Department - the Clinical Expert Operating System Chest Pain Danderyd Study (CLEOS-CPDS): Prospective Cohort Study.

Brandberg H; Sundberg CJ; Spaak J; Koch S; Zakim D; Kahan T
Article: MICROCIRCULATION. 2021;28(2):e12670

Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study.

Östlund Papadogeorgos N; Kuhl J; Shore A; Kahan T; Jörneskog G; Kalani M
Article: JOURNAL OF HYPERTENSION. 2021;39(1):190-195

The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension.
Article: PLOS ONE. 2021;16(9):e0257677

Computerized history-taking improves data quality for clinical decision-making-Comparison of EHR and computer-acquired history data in patients with chest pain.

Zakim D; Brandberg H; El Amrani S; Hultgren A; Stathakarou N; Nifakos S; Kahan T; Spaak J; Koch S; Sundberg CJ
Article: JOURNAL OF INTERNAL MEDICINE. 2020;288(5):581-592

Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction.

Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mörtberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallén HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(6):384-393

Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension.

Cífková R; Johnson MR; Kahan T; Brguljan J; Williams B; Coca A; Manolis A; Thomopoulos C; Borghi C; Tsioufis C; Parati G; Sudano I; McManus RJ; van den Born B-JH; Regitz-Zagrosek V; de Simone G
Article: BLOOD PRESSURE. 2020;29(3):168-174

Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity.

Wallentin F; Wettermark B; Kahan T
Article: JOURNAL OF HYPERTENSION. 2020;38(5):799-812

Nutraceuticals and blood pressure control: a European Society of Hypertension position document.

Borghi C; Tsioufis K; Agabiti-Rosei E; Burnier M; Cicero AFG; Clement D; Coca A; Desideri G; Grassi G; Lovic D; Lurbe E; Kahan T; Kreutz R; Jelakovic B; Polonia J; Redon J; Van De Borne P; Mancia G
Article: RESUSCITATION. 2020;150:130-138

ECG-monitoring of in-hospital cardiac arrest and factors associated with survival.

Thorén A; Rawshani A; Herlitz J; Engdahl J; Kahan T; Gustafsson L; Djärv T
Article: ESC HEART FAILURE. 2020;7(2):737-746

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study.

Ekström M; Hellman A; Hasselström J; Hage C; Kahan T; Ugander M; Wallén H; Persson H; Linde C
Article: BMJ OPEN. 2020;10(1):e031871

A prospective cohort study of self-reported computerised medical history taking for acute chest pain: protocol of the CLEOS-Chest Pain Danderyd Study (CLEOS-CPDS).

Brandberg H; Kahan T; Spaak J; Sundberg K; Koch S; Adeli A; Sundberg CJ; Zakim D
Article: BIOMED RESEARCH INTERNATIONAL. 2020;2020:8571062-7

Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle-Aged, Apparently Healthy Population.

Böcskei RM; Benczúr B; Müller V; Bikov A; Székely A; Kahan T; Lenkey Z; Husznai R; Cziráki A; Illyés M
Article: JOURNAL OF HYPERTENSION. 2020;38(1):167-175

Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.

Bokrantz T; Schiöler L; Boström KB; Kahan T; Mellström D; Ljungman C; Hjerpe P; Hasselström J; Manhem K
Article: PLOS ONE. 2020;15(8):e0237107

The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD).

Andersson T; Pikkemaat M; Schiöler L; Hjerpe P; Carlsson AC; Wändell P; Manhem K; Kahan T; Hasselström J; Bengtsson Boström K
Article: BLOOD PRESSURE. 2019;28(5):309-316

Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients.

Qvarnström M; Kahan T; Kieler H; Brandt L; Hasselström J; Wettermark B
Article: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 2019;48(Suppl 102):1-79

ESVM Guideline on peripheral arterial disease.

Frank U; Nikol S; Belch J; Boc V; Brodmann M; Carpentier PH; Chraim A; Canning C; Dimakakos E; Gottsäter A; Heiss C; Mazzolai L; Madaric J; Olinic DM; Pécsvárady Z; Poredoš P; Quéré I; Roztocil K; Stanek A; Vasic D; Visonà A; Wautrecht J-C; Bulvas M; Colgan M-P; Dorigo W; Houston G; Kahan T; Lawall H; Lindstedt I; Mahe G; Martini R; Pernod G; Przywara S; Righini M; Schlager O; Terlecki P
Article: HEART AND VESSELS. 2019;34(3):484-495

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril study.

Jekell A; Kalani M; Kahan T
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):37-46

ESC Council on hypertension position document on the management of hypertensive emergencies.

van den Born B-JH; Lip GYH; Brguljan-Hitij J; Cremer A; Segura J; Morales E; Mahfoud F; Amraoui F; Persu A; Kahan T; Agabiti Rosei E; de Simone G; Gosse P; Williams B
Article: DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION. 2019;2019:baz085

Large expert-curated database for benchmarking document similarity detection in biomedical literature search.

Brown P; RELISH Consortium; Zhou Y
Article: BMJ OPEN. 2018;8(12):e021038

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.

Parati G; Agabiti-Rosei E; Bakris GL; Bilo G; Branzi G; Cecchi F; Chrostowska M; De la Sierra A; Domenech M; Dorobantu M; Faria T; Huo Y; Jelaković B; Kahan T; Konradi A; Laurent S; Li N; Madan K; Mancia G; McManus RJ; Modesti PA; Ochoa JE; Octavio JA; Omboni S; Palatini P; Park JB; Pellegrini D; Perl S; Podoleanu C; Pucci G; Redon J; Renna N; Rhee MY; Rodilla Sala E; Sanchez R; Schmieder R; Soranna D; Stergiou G; Stojanovic M; Tsioufis K; Valsecchi MG; Veglio F; Waisman GD; Wang JG; Wijnmaalen P; Zambon A; Zanchetti A; Zhang Y
Article: BLOOD PRESSURE. 2018;27(6):314-340

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B; Mancia G; Spiering W; Agabiti Rosei E; Azizi M; Burnier M; Clement D; Coca A; De Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen S; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder R; Shlyakhto E; Tsioufis K; Aboyans V; Desormais I
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2018;122(1):102-107

Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD]).

Mourtzinis G; Kahan T; Bengtsson Boström K; Schiöler L; Cedstrand Wallin L; Hjerpe P; Hasselström J; Manhem K
Article: JOURNAL OF HYPERTENSION. 2018;36(4):857-866

Cardiac function, myocardial mechano-energetic efficiency, and ventricular-arterial coupling in normal pregnancy.

Iacobaeus C; Andolf E; Thorsell M; Bremme K; Östlund E; Kahan T
Article: HYPERTENSION. 2018;71(4):540-547

Management of a Pregnant Woman With Fibromuscular Dysplasia.

Berra E; Dominiczak AF; Touyz RM; Pierard S; Hammer F; Rossi GP; Micali RG; Staessen JA; Bursztyn M; Kahan T; Persu A
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2018;71(4):240-247

Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.

Ekholm M; Jekell A; Wallén NH; Gigante B; Kahan T
Article: BLOOD PRESSURE. 2018;27(2):88-98

The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study.

Jekell A; Kahan T
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2018;51(3):361-367

Pregnancy-associated plasma protein-A is positively correlated with first-trimester skin microvascular reactivity.

Iacobaeus C; Kahan T; Jörneskog G; Bremme K; Andolf E; Thorsell M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(3):315-321

Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Holmqvist L; Boström KB; Kahan T; Schiöler L; Qvarnström M; Wettermark B; Hjerpe P; Hasselström J; Manhem K
Article: JOURNAL OF HYPERTENSION. 2018;36(2):402-409

Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Holmqvist L; Boström KB; Kahan T; Schiöler L; Hasselström J; Hjerpe P; Wettermark B; Manhem K
Article: JOURNAL OF HYPERTENSION. 2018;36(1):151-158

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.

Völz S; Spaak J; Elf J; Jägrén C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
Article: JOURNAL OF CLINICAL HYPERTENSION. 2018;20(1):106-114

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity.

Wallentin F; Wettermark B; Kahan T
Article: JOURNAL OF HYPERTENSION. 2017;35(10):2102-2108

Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database.

Holmquist C; Hasselström J; Bengtsson Boström K; Manhem K; Wettermark B; Hjerpe P; Kahan T
Article: BLOOD PRESSURE. 2017;26(5):294-302

The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study.

Gordin D; Fadl Elmula FEM; Andersson B; Gottsäter A; Elf J; Kahan T; Christensen KL; Vikatmaa P; Vikatmaa L; Bastholm Olesen T; Groop P-H; Olsen MH; Tikkanen I; Nordic BAT Study Group
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2017;18(9):945-960

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH).

Perrone-Filardi P; Coca A; Galderisi M; Paolillo S; Alpendurada F; de Simone G; Donal E; Kahan T; Mancia G; Redon J; Schmieder R; Williams B; Agabiti-Rosei E
Article: JOURNAL OF HYPERTENSION. 2017;35(9):1727-1741

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension.

Perrone-Filardi P; Coca A; Galderisi M; Paolillo S; Alpendurada F; de Simone G; Donal E; Kahan T; Mancia G; Redon J; Schmieder R; Williams B; Agabiti-Rosei E
Article: BLOOD PRESSURE. 2017;26(4):220-228

Non-steroidal anti-inflammatory drugs and blood pressure control in patients treated for hypertension: results from the Swedish primary care cardiovascular database.

Ljungman C; Kahan T; Schiöler L; Wettermark B; Boström KB; Hasselström J; Hjerpe P; Manhem K
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2017;24(11):1206-1211

Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Mourtzinis G; Schiöler L; Kahan T; Bengtsson Boström K; Hjerpe P; Hasselström J; Manhem K
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2017;119(12):2042-2048

Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.

Löfsjögård J; Kahan T; Díez J; López B; González A; Ravassa S; Mejhert M; Edner M; Persson H
Article: HEART AND VESSELS. 2017;32(6):674-684

The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.

Jekell A; Kalani M; Kahan T
Article: EUROPACE. 2017;19(6):891-911

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Lip GYH; Coca A; Kahan T; Boriani G; Manolis AS; Olsen MH; Oto A; Potpara TS; Steffel J; Marín F; de Oliveira Figueiredo MJ; de Simone G; Tzou WS; Chiang C-E; Williams B; Reviewers:; Dan G-A; Gorenek B; Fauchier L; Savelieva I; Hatala R; van Gelder I; Brguljan-Hitij J; Erdine S; Lovic D; Kim Y-H; Salinas-Arce J; Field M
Article: JOURNAL OF HYPERTENSION. 2017;35(1):188-197

Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database.

Bokrantz T; Ljungman C; Kahan T; Boström KB; Hasselström J; Hjerpe P; Mellström D; Schiöler L; Manhem K
Article: JOURNAL OF HYPERTENSION. 2016;34(11):2187-2198

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.

Omboni S; Aristizabal D; De la Sierra A; Dolan E; Head G; Kahan T; Kantola I; Kario K; Kawecka-Jaszcz K; Malan L; Narkiewicz K; Octavio JA; Ohkubo T; Palatini P; Siègelovà J; Silva E; Stergiou G; Zhang Y; Mancia G; Parati G; ARTEMIS (international Ambulatory blood pressure R
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2016;10(11):838-846

Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database.

Holmqvist L; Boström KB; Kahan T; Schiöler L; Hasselström J; Hjerpe P; Wettermark B; Manhem K
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2016;48(4):483-490

Fetal growth is associated with first-trimester maternal vascular function.

Iacobaeus C; Kahan T; Jörneskog G; Bremme K; Thorsell M; Andolf E
Article: MEDICINE. 2016;95(40):e4908

Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).

Qvarnström M; Kahan T; Kieler H; Brandt L; Hasselström J; Boström KB; Manhem K; Hjerpe P; Wettermark B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2016;72(8):965-975

How to best assess quality of drug treatment in patients with heart failure.

Zarrinkoub R; Kahan T; Johansson S-E; Wändell P; Mejhert M; Wettermark B
Article: CARDIOVASCULAR DIABETOLOGY. 2016;15:66

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome.

Östlund Papadogeorgos N; Jörneskog G; Bengtsson M; Kahan T; Kalani M
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2016;10(4):297-306

Cardiac structure and function, and ventricular-arterial interaction 11 years following a pregnancy with preeclampsia.

Al-Nashi M; Eriksson MJ; Östlund E; Bremme K; Kahan T
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2016;27(1):113-116

Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia.

Ekholm M; Kahan T; Jörneskog G; Bröijersén A; Wallén NH
Article: LAKARTIDNINGEN. 2015;112:DT9A

[More rigorous blood pressure control yields results in high risk patients. American SPRINT provides increased evidence of the benefits of prevention].

Gottsäter A; Kahan T; Nilsson P
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2015;16(2):328-338

Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion.

Ekholm M; Kahan T; Jörneskog G; Brinck J; Wallén NH
Article: JOURNAL OF HUMAN HYPERTENSION. 2015;29(6):385-393

Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD).

Ljungman C; Kahan T; Schiöler L; Hjerpe P; Wettermark B; Boström KB; Manhem K
Article: VALUE IN HEALTH. 2015;18(4):439-448

Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry.

Berg J; Lindgren P; Mejhert M; Edner M; Dahlström U; Kahan T
Article: BMC NEUROLOGY. 2015;15:67

Elevated blood lipids are uncommon in patients with post-polio syndrome--a cross sectional study.

Melin E; Kahan T; Borg K
Article: EUROPEAN JOURNAL OF GENERAL PRACTICE. 2015;21(1):26-32

A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.

Mejhert M; Kahan T
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2014;8(12):882-890

Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Ljungman C; Kahan T; Schiöler L; Hjerpe P; Hasselström J; Wettermark B; Boström KB; Manhem K
Article: JOURNAL OF HYPERTENSION. 2014;32(12):2422-2427

Hyperresponders vs. nonresponder patients after renal denervation: do they differ?

Persu A; Azizi M; Jin Y; Volz S; Rosa J; Fadl Elmula FEM; Pechere-Bertschi A; Burnier M; Mark PB; Elvan A; Renkin J; Sapoval M; Kahan T; Kjeldsen S; Staessen JA; European Network COordinating research on Renal De
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2014;48(5):299-303

Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure.

Löfsjögård J; Persson H; Díez J; López B; González A; Edner M; Mejhert M; Kahan T
Article: JOURNAL OF CARDIOVASCULAR MEDICINE. 2014;15(6):463-469

Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure.

Löfsjögård J; Kahan T; Díez J; López B; González A; Edner M; Henriksson P; Mejhert M; Persson H
Article: HYPERTENSION. 2014;63(6):1319-1325

Eligibility for renal denervation: experience at 11 European expert centers.

Persu A; Jin Y; Baelen M; Vink E; Verloop WL; Schmidt B; Blicher MK; Severino F; Wuerzner G; Taylor A; Pechère-Bertschi A; Jokhaji F; Fadl Elmula FEM; Rosa J; Czarnecka D; Ehret G; Kahan T; Renkin J; Widimsky J; Jacobs L; Spiering W; Burnier M; Mark PB; Menne J; Olsen MH; Blankestijn PJ; Kjeldsen S; Bots ML; Staessen JA; European Network Coordinating research on REnal De
Article: BLOOD PRESSURE. 2014;23(2):116-125

The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients.

Hasselström J; Zarrinkoub R; Holmquist C; Hjerpe P; Ljungman C; Qvarnström M; Wettermark B; Manhem K; Kahan T; Bengtsson Boström K
Article: JOURNAL OF HUMAN HYPERTENSION. 2014;28(3):150-156

Blood pressure changes after renal denervation at 10 European expert centers.

Persu A; Jin Y; Azizi M; Baelen M; Völz S; Elvan A; Severino F; Rosa J; Adiyaman A; Fadl Elmula FE; Taylor A; Pechère-Bertschi A; Wuerzner G; Jokhaji F; Kahan T; Renkin J; Monge M; Widimský P; Jacobs L; Burnier M; Mark PB; Kjeldsen SE; Andersson B; Sapoval M; Staessen JA; European Network COordinating research on Renal De
Article: JRSM CARDIOVASCULAR DISEASE. 2014;3:2048004014548735-204800401454873

Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failure.

Berg J; Lindgren P; Kahan T; Schill O; Persson H; Edner M; Mejhert M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2013;62(6):559-566

Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study.

Jekell A; Malmqvist K; Wallén NH; Mörtsell D; Kahan T
Article: HYPERTENSION RESEARCH. 2013;36(12):1081-1087

Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia.

Östlund E; Al-Nashi M; Hamad RR; Larsson A; Eriksson M; Bremme K; Kahan T
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(11):1955-1964

Persistence to antihypertensive drug treatment in Swedish primary healthcare.

Qvarnström M; Kahan T; Kieler H; Brandt L; Hasselström J; Bengtsson Boström K; Manhem K; Hjerpe P; Wettermark B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;168(2):789-794

Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.

Tardif J-C; Ponikowski P; Kahan T; ASSOCIATE Investigators
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2013;15(9):995-1002

The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden.

Zarrinkoub R; Wettermark B; Wändell P; Mejhert M; Szulkin R; Ljunggren G; Kahan T
Article: JOURNAL OF HYPERTENSION. 2013;31(8):1676-1682

Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.

Schwieler JH; Kahan T; Wallén NH; Nussberger J; Hjemdahl P
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2013;41(6):637-643

Large differences between patients with acute myocardial infarction included in two Swedish health registers.

Aspberg S; Stenestrand U; Köster M; Kahan T
Article: JOURNAL OF HYPERTENSION. 2013;31(7):1281-1357

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; Fagard R; Narkiewicz K; Redón J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Task Force Members
Article: LAKARTIDNINGEN. 2013;110(22):1088-1089

[Hypertension is the greatest threat to global health. Increases the risk of cardiovascular disease, dementia and kidney disease].

Kahan T; Carlberg B; Nilsson PM
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2013;24(3):260-265

Long term health care consumption and cost expenditure in systolic heart failure.

Mejhert M; Lindgren P; Schill O; Edner M; Persson H; Kahan T
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2013;43(2):141-151

Risk prediction in stable angina pectoris.

Kahan T; Forslund L; Held C; Björkander I; Billing E; Eriksson SV; Näsman P; Rehnqvist N; Hjemdahl P
Article: LAKARTIDNINGEN. 2013;110(3):76

[Resistant hypertension: new perspectives for difficult-to-treat group].

Kahan T
Article: PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH. 2012;2(3):261-262

PP037. Family history of cardiovascular disease and maternal vascular function during early pregnancy.

Iacobaeus C; Jörneskog G; Kahan T; Thorsell M; Andolf E
Article: PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH. 2012;2(3):223

OS083. Fetal growth and maternal vascular function in early pregnancy.

Iacobaeus C; Jörneskog G; Kahan T; Thorsell M; Andolf E
Article: JOURNAL OF HUMAN HYPERTENSION. 2011;25(8):484-491

Antihypertensive treatment and control in a large primary care population of 21 167 patients.

Qvarnström M; Wettermark B; Ljungman C; Zarrinkoub R; Hasselström J; Manhem K; Sundström A; Kahan T
Article: CEREBROVASCULAR DISEASES EXTRA. 2011;1(1):66-74

A randomized controlled trial on very early speech and language therapy in acute stroke patients with aphasia.

Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2010;64(9):1228-1234

The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.

Lindgren P; Eriksson J; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B; ASCOT trial investigators
Article: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2010;21(4 Pt 2):e733-e739

Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma.

Aspberg S; Dahlquist G; Kahan T; Källén B
Article: BLOOD PRESSURE. 2010;19(3):176-181

Cardiovascular risk factors are not treated to target in hypertensive patients in primary care.

Nieburg I; Kahan T
Article: HEALTH POLICY. 2010;94(3):221-229

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment.

Wettermark B; Godman B; Neovius M; Hedberg N; Mellgren T-O; Kahan T
Article: LAKARTIDNINGEN. 2009;106(32-33):1992-1994

[SBU should investigate what is an evidence-based and cost-effective use of statins].

Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Article: ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES. 2009;26(7):753-758

The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).

Liljedahl S; Kahan T; Lind L; Arnlöv J
Article: LAKARTIDNINGEN. 2009;106(20):1349-1350

[Correctly measured blood pressure, thanks!].

Kahan T
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2009;29(3):201-208

Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.

Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Article: THROMBOSIS RESEARCH. 2009;124(1):110-115

Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.

Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
Article: EUROPEAN HEART JOURNAL. 2009;30(5):540-548

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif J-C; Ponikowski P; Kahan T; ASSOCIATE Study Investigators
Article: PHARMACOECONOMICS. 2009;27(3):221-230

The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.

Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B; ASCOT investigators
Article: JOURNAL OF CARDIOVASCULAR MEDICINE. 2008;9(10):1037-1044

Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia.

Jörneskog G; Kahan T; Ekholm M; Bröijersén A; Wallén NH
Article: AMERICAN JOURNAL OF HYPERTENSION. 2008;21(7):836-839

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.

Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen A-C; Lind L; Kahan T
Article: TOPICS IN STROKE REHABILITATION. 2008;15(3):256-261

Design and methods of a randomized controlled trial on early speech and language therapy in patients with acute stroke and aphasia.

Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
Article: JOURNAL OF WOMENS HEALTH. 2008;17(3):373-381

Sex differences in systolic heart failure in the elderly: the prognostic importance of left ventricular mass in women.

Mejhert M; Kahan T; Edner M; Persson HE
Article: CARDIOLOGY. 2008;111(2):126-133

Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.

Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
Article: JOURNAL OF HUMAN HYPERTENSION. 2007;21(12):956-965

Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study.

Malmqvist K; Kahan T; Edner M; Bergfeldt L
Article: JOURNAL OF HYPERTENSION. 2007;25(9):1958-1966

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Müller-Brunotte R; Kahan T; López B; Edner M; González A; Díez J; Malmqvist K
Article: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2007;18(4):313-319

Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?

Aspberg S; Dahlquist G; Kahan T; Källén B
Journal article: EUROPEAN HEART JOURNAL. 2007;28(12):1105-1187

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Struijker Boudier HAJ; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Kjeldsen SE; Erdine S; Narkiewicz K; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Cifkova R; Dominiczak A; Fagard R; Heagerty AM; Laurent S; Lindholm LH; Mancia G; Manolis A; Nilsson PM; Redon J; Schmieder RE; Struijker-Boudier HAJ; Viigimaa M; Filippatos G; Adamopoulos S; Agabiti-Rosei E; Ambrosioni E; Bertomeu V; Clement D; Erdine S; Farsang C; Gaita D; Kiowski W; Lip G; Mallion J-M; Manolis AJ; Nilsson PM; O'Brien E; Ponikowski P; Redon J; Ruschitzka F; Tamargo J; van Zwieten P; Viigimaa M; Waeber B; Williams B; Zamorano JL; The task force for the management of arterial hype; The task force for the management of arterial hype
Journal article: JOURNAL OF HYPERTENSION. 2007;25(6):1462-1536

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Boudier HAJS; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Erdine S; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Lindholm LH; Viigimaa M; Adamopoulos S; Agabiti-Rosei E; Ambrosioni E; Bertomeu V; Clement D; Erdine S; Farsang C; Gaita D; Lip G; Mallion J-M; Manolis AJ; Nilsson PM; O'Brien E; Ponikowski P; Redon J; Ruschitzka F; Tamargo J; van Zwieten P; Waeber B; Williams B; Management of Arterial Hypertension of the Europea; European Society of Cardiology
Article: JOURNAL OF REHABILITATION MEDICINE. 2007;39(5):387-392

Clinical and prognostic properties of standardized and functional aphasia assessments.

Laska AC; Bartfai A; Hellblom A; Murray V; Kahan T
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(5):472-479

Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.

Mörtsell D; Malmqvist K; Held C; Kahan T
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2007;8(1):25-30

Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy.

Lindgren P; Kahan T; Poulter N; Buxton M; Svarvar P; Dahlöf B; Jonsson B; ASCOT investigators
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(2):148-158

Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris.

Sundkvist GMG; Hjemdahl P; Kahan T; Melcher A
Article: CEREBROVASCULAR DISEASES. 2007;24(1):74-79

Recognition of depression in aphasic stroke patients.

Laska AC; Mårtensson B; Kahan T; von Arbin M; Murray V
Article: JOURNAL OF HYPERTENSION. 2007;25(1):169-175

Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.

Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
Article: AMERICAN JOURNAL OF HYPERTENSION. 2006;19(9):927-936

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).

Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Article: ACTA PAEDIATRICA. 2006;95(8):1001-1004

Fetal and perinatal risk factors for inflammatory bowel disease.

Aspberg S; Dahlquist G; Kahan T; Källén B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2006;109(1):108-113

Predicting readmissions and cardiovascular events in heart failure patients.

Mejhert M; Kahan T; Persson H; Edner M
Article: JOURNAL OF INTERNAL MEDICINE. 2005;257(6):514-522

Nurse-recorded clinic and ambulatory blood pressures correlate equally well with left ventricular mass and carotid intima-media thickness.

Nyström F; Malmqvist K; Lind L; Kahan T
Article: JOURNAL OF HYPERTENSION. 2005;23(3):633-640

Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy.

Müller-Brunotte R; Edner M; Malmqvist K; Kahan T
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2005;98(3):493-499

Differential index, a novel graphical method for measurements of heart rate variability.

Björkander I; Kahan T; Ericson M; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: HEART. 2005;91(2):250-256

Left ventricular hypertrophy in hypertension: its arrhythmogenic potential.

Kahan T; Bergfeldt L
Article: JOURNAL OF CARDIOVASCULAR RISK. 2005;12(1):29-36

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B; ASCOT investigators
Article: CEREBROVASCULAR DISEASES. 2005;19(2):125-132

Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study.

Laska AC; von Arbin M; Kahan T; Hellblom A; Murray V
Article: JOURNAL OF HYPERTENSION. 2004;22(12):2321-2328

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.

Liljedahl U; Kahan T; Malmqvist K; Melhus H; Syvänen A-C; Lind L; Kurland L
Article: BMC CARDIOVASCULAR DISORDERS. 2004;4(1):16

Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.

Liljedahl U; Lind L; Kurland L; Berglund L; Kahan T; Syvänen A-C
Article: HEART. 2004;90(9):1010-1015

Limited long term effects of a management programme for heart failure.

Mejhert M; Kahan T; Persson H; Edner M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2004;96(2):183-189

Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?

Quintana M; Edner M; Kahan T; Hjemdahl P; Sollevi A; Rehnqvist N
Article: CLINICAL CARDIOLOGY. 2004;27(6):347-350

Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.

Karlsson J; Lind L; Hallberg P; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
Article: CLINICAL CARDIOLOGY. 2004;27(5):287-290

Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Hallberg P; Karlsson J; Lind L; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
Article: CLINICAL CARDIOLOGY. 2004;27(3):169-173

Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen A-C; Melhus H
Article: CORONARY ARTERY DISEASE. 2004;15(1):31-37

Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit.

Yu W; Maru F; Edner M; Hellström K; Kahan T; Persson H
Article: BLOOD PRESSURE. 2004;13(3):152-157

A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).

Brändström H; Stiger F; Kahan T; Melhus H; Nyström F; öHman KP; Malmqvist K; Lind L; Kindmark A
Article: AMERICAN JOURNAL OF HYPERTENSION. 2004;17(1):8-13

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

Kurland L; Liljedahl U; Karlsson J; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2003;42(6):719-726

Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
Article: JOURNAL OF HUMAN HYPERTENSION. 2003;17(12):841-849

Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy.

Müller-Brunotte R; Kahan T; Malmqvist K; Edner M; Swedish ibesartan left ventricular hypertrophy inv
Article: BMC CARDIOVASCULAR DISORDERS. 2003;3:11

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.

Hallberg P; Lind L; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen A-C; Melhus H
Article: LAKARTIDNINGEN. 2003;100(21):1919-1920

[The Swedish Society of Hypertension: cooperation with industry is desirable and necessary--with integrity preserved].

Nilsson P; Hedner T; Himmelmann A; Kahan T; Manhem K; Norrvinsdotter-Borg I; Nyström F; Svensson P; Wallén T
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(1):1-9

Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr A-C; Näsman P; ATTACC investigators
Article: JOURNAL OF HYPERTENSION. 2003;21(3):621-624

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.

Hallberg P; Lind L; Michaëlsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
Article: PHARMACOGENETICS AND GENOMICS. 2003;13(1):7-17

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.

Liljedahl U; Karlsson J; Melhus H; Kurland L; Lindersson M; Kahan T; Nyström F; Lind L; Syvänen A-C
Article: ATHEROSCLEROSIS. 2002;165(2):271-276

Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals.

Holmlund A; Hulthe J; Millgård J; Sarabi M; Kahan T; Lind L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2002;90(10):1107-1112

Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).

Malmqvist K; Kahan T; Edner M; Bergfeldt L
Article: JOURNAL OF INTERNAL MEDICINE. 2002;252(5):430-439

Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.

Malmqvist K; Ohman KP; Lind L; Nyström F; Kahan T
Article: JOURNAL OF HYPERTENSION. 2002;20(10):2089-2093

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

Hallberg P; Karlsson J; Kurland L; Lind L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Melhus H
Article: HEART. 2002;88(3):239-243

Ventilatory variables are strong prognostic markers in elderly patients with heart failure.

Mejhert M; Linder-Klingsell E; Edner M; Kahan T; Persson H
Article: JOURNAL OF HYPERTENSION. 2002;20(8):1563-1569

Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.

Malmqvist K; Wallén HN; Held C; Kahan T
Article: JOURNAL OF HYPERTENSION. 2002;20(8):1527-1533

Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.

Nyström F; Malmqvist K; Ohman KP; Kahan T
Article: CLINICAL SCIENCE. 2002;103(2):151-155

Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension.

Ekholm M; Wallén NH; Johnsson H; Eliasson K; Kahan T
Article: JOURNAL OF INTERNAL MEDICINE. 2002;251(6):508-517

The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study.

Björholt I; Andersson FL; Kahan T; Ostergren J
Article: AMERICAN JOURNAL OF HYPERTENSION. 2002;15(5):389-393

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.

Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
Article: HEART. 2002;87(5):415-422

Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris.

Forslund L; Björkander I; Ericson M; Held C; Kahan T; Rehnqvist N; Hjemdahl P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2002;293(1):13-17

A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function.

Brändström H; Stiger F; Lind L; Kahan T; Melhus H; Kindmark A
Article: JOURNAL OF HYPERTENSION. 2002;20(4):657-663

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.

Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
Article: LIPIDS. 2002;37(3):231-236

Cardiac and vascular structure and function are related to lipid peroxidation and metabolism.

Steer P; Millgård J; Sarabi DM; Basu S; Vessby B; Kahan T; Edner M; Lind L
Article: JOURNAL OF CARDIOVASCULAR RISK. 2002;9(1):53-57

Endothelium-dependent vasodilation is impaired in apparently healthy subjects with a family history of myocardial infarction.

Lind L; Sarabi M; Millgård J; Kahan T
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2002;4(1):73-82

Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists.

Persson H; Andréasson K; Kahan T; Eriksson SV; Tidgren B; Hjemdahl P; Hall C; Erhardt L
Article: JOURNAL OF HYPERTENSION. 2001;19(10):1813-1818

Treatment with irbesartan or atenolol improves endothelial function in essential hypertension.

von zur Mühlen B; Kahan T; Hägg A; Millgård J; Lind L
Article: JOURNAL OF HYPERTENSION. 2001;19(10):1783-1787

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.

Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman KP; Nyström F; Hägg A; Lind L; Swedish Irbesartan Left Ventricular Hypertrophy In
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15 Suppl 1:S91-S93

The effects of cardiac events on quality of life and indirect costs.

Jönsson B; Buxton M; Kahan T; Poulter NR; Svarvar P; Anglo-Scandinavian Cardiac Outcomes Trial, Health
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15 Suppl 1:S53-S56

Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Jönsson B; Buxton M; Hertzman P; Kahan T; Poulter N; Anglo-Scandinavian Cardiac Outcomes Trial, Health
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1167-1176

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

Malmqvist K; Kahan T; Edner M; Held C; Hägg A; Lind L; Müller-Brunotte R; Nyström F; Ohman KP; Osbakken MD; Ostergern J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(5):413-422

Aphasia in acute stroke and relation to outcome.

Laska AC; Hellblom A; Murray V; Kahan T; Von Arbin M
Article: JOURNAL OF CARDIOVASCULAR RISK. 2001;8(2):73-80

Risk factors in established coronary heart disease: evaluation of a secondary prevention programme.

Kahan T; Wändell P
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2001;21(2):196-207

Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes.

Malmqvist K; Kahan T; Eriksson S; Björkander I; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 2001;19(2):311-317

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension.

Malmqvist K; Isaksson H; Ostergren J; Kahan T
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2001;3(1):69-78

Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.

Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Article: BLOOD PRESSURE. 2001;10(2):101-110

Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism.

Malmqvist K; Kahan T; Isaksson H; Ostergren J
Article: CORONARY ARTERY DISEASE. 2000;11(7):523-526

Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction.

Kahan T; Lundman P; Olsson G; Wendt M
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(2):159-164

Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden.

Rosén M; Alfredsson L; Hammar N; Kahan T; Spetz CL; Ysberg AS
Article: EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY. 2000;1(2):87-95

Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indices.

Edner M; Jarnert C; Müller-Brunotte R; Malmqvist K; Ring M; Kjerr AC; Lind L; Kahan T
Article: AMERICAN JOURNAL OF HYPERTENSION. 2000;13(5 Pt 1):504-511

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.

Malmqvist K; Kahan T; Dahl M
Article: BLOOD PRESSURE. 2000;9(6):309-314

Left ventricular hypertrophy is associated with an attenuated endothelium-dependent vasodilation in hypertensive men.

Millgård J; Hägg A; Kahan T; Landelius J; Malmqvist K; Sarabi M; Lind L
Article: AMERICAN JOURNAL OF HYPERTENSION. 1999;12(12 Pt 1-2):1188-1194

The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension.

Kahan T; Eliasson K
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1999;19(5):400-409

Endothelium-dependent vasodilation and structural and functional changes in the cardiovascular system are dependent on age in healthy subjects.

Lind L; Sarabi M; Millgård J; Kahan T; Edner M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1999;34(2):268-274

Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans.

Schwieler JH; Ericsson H; Löfdahl P; Thulin T; Kahan T
Article: BLOOD PRESSURE. 1999;8(3):158-164

Endothelium-dependent vasodilatation in treated and untreated hypertensive subjects.

Lind L; Millgård J; Sarabi M; Kahan T; Malmqvist K; Hägg A
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759

Adrenaline responsiveness in mild hypertension: no evidence for altered beta-adrenoceptor sensitivity.

Kahan T; Hjemdahl P; Lindvall K; Ostergren J; de Faire U
Article: ACTA PHYSIOLOGICA. 1997;159(2):107-111

Plasma angiotensins and human forearm circulation: effects of sympatho-adrenal activation.

Kahan T; Lindqvist M; Nussberger J; Melcher A; Hjemdahi P
Article: LAKARTIDNINGEN. 1996;93(42):3697-3700

[A model for study of quality of myocardial infarction care. Distinct targets improve the care].

Forslund L; Kahan T; Nilsson R; Norhagen PH; Adamson U
Article: HAEMOSTASIS. 1996;26(5):247-257

Anticoagulant effects of low-molecular-weight heparin following thrombolytic therapy in acute myocardial infarction: a dose-finding study.

Strandberg LE; Kahan T; Lundin P; Svensson J; Erhardt L
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1996;270(3 Pt 1):E393-E399

Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP.

Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
Visa fler

Alla övriga publikationer

Other: BLOOD PRESSURE. 2024;33(1):2317263

Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?

Kreutz R; Azizi M; Grassi G; Januszewicz A; Kahan T; Lurbe E; Polonia J; Tsioufis K; Weber T; Williams B; Mancia G
Editorial comment: EUROPEAN HEART JOURNAL OPEN. 2023;4(1):oeae008

Editors' highlight picks from 2023 in EHJ Open.

Bäck M; Banach M; Braunschweig F; De Rosa S; Flachskampf FA; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Nagy E; Savarese G; Szummer K; Wahl D; European Heart Journal Open Section Editors
Editorial comment: EUROPEAN HEART JOURNAL OPEN. 2022;2(6):oeac084

Highlights from 2022 in EHJ Open.

Bäck M; Banach M; Braunschweig F; De Rosa S; Gimelli A; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Nagy E; Savarese G; Szummer K; Wahl D; European Heart Journal Open Section Editors
Editorial comment: KARDIOLOGIA POLSKA. 2022;80(3):350-352

Does sodium and potassium intake assessment by diet-related mobile applications do more harm than good?

Sobieraj P; Bzikowska-Jura A; Raciborski F; Kucharska A; Szostak-Węgierek D; Kahan T
Conference publication: JOURNAL OF HYPERTENSION. 2022;40(SUPPL):E9

BLOOD PRESSURE IN ATRIAL FIBRILLATION AND IN SINUS RHYTHM DURING 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING: DATA FROM THE TEMPLAR PROJECT

Lundwall K; Kahan T; Omboni S
Review: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 2021;50(6):401-411

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgözoğlu L
Editorial comment: LANCET. 2021;398(10305):1022-1023

Low-dose combination of blood pressure-lowering medicines.

Kahan T
Review: EUROPEAN HEART JOURNAL. 2021;42(35):3427-3520

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

Glikson M; Nielsen JC; Kronborg MB; Michowitz Y; Auricchio A; Barbash IM; Barrabés JA; Boriani G; Braunschweig F; Brignole M; Burri H; Coats AJS; Deharo J-C; Delgado V; Diller G-P; Israel CW; Keren A; Knops RE; Kotecha D; Leclercq C; Merkely B; Starck C; Thylén I; Tolosana JM; ESC Scientific Document Group
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):242-250

Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Mancusi C; de Simone G; Brguljan Hitij J; Sudano I; Mahfoud F; Parati G; Kahan T; Barbato E; Pierard LA; Garbi M; Flachskampf FA; Gerdts E
Editorial comment: LANCET. 2021;397(10285):1598-1599

Decisions about antihypertensive treatment should focus on reducing cardiovascular risk.

Kahan T
Review: FRONTIERS IN PHARMACOLOGY. 2021;12:640185

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.

Ekholm M; Kahan T
Review: LAKARTIDNINGEN. 2020;117:20102

[Hypertension, RAAS blockade and risk in COVID-19 patients].

Spaak J; Kahan T
Editorial comment: LANCET. 2019;394(10199):615-617

Strategies to identify patients for antihypertensive treatment.

Kahan T
Review: CURRENT PHARMACEUTICAL DESIGN. 2019;24(37):4391-4396

Treatment of Hypertensive Left Ventricular Hypertrophy.

Jekell A; Nilsson PM; Kahan T
Letter: JOURNAL OF HYPERTENSION. 2019;37(2):449-451

Reply.

Völz S; Spaak J; Rundqvist B; Kahan T; Andersson B; all authors
Letter: JOURNAL OF HYPERTENSION. 2018;36(8):1770-1771

Reply.

Iacobaeus C; Andolf E; Thorsell M; Bremme K; Östlund E; Kahan T
Review: PHARMACOECONOMICS. 2018;36(2):205-213

Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe.

Hermansson J; Kahan T
Review: JOURNAL OF HYPERTENSION. 2018;36(2):221-229

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.

Persu A; Gordin D; Jacobs L; Thijs L; Bots ML; Spiering W; Miroslawska A; Spaak J; Rosa J; de Jong MR; Berra E; Fadl Elmula FEM; Wuerzner G; Taylor AHM; Olszanecka A; Czarnecka D; Mark PB; Burnier M; Renkin J; Kjeldsen SE; Widimský J; Elvan A; Kahan T; Steigen TK; Blankestijn PJ; Tikkanen I; Staessen JA; European Network COordinating research on Renal De
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(4):235-250

Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Lip GYH; Coca A; Kahan T; Boriani G; Manolis AS; Olsen MH; Oto A; Potpara TS; Steffel J; Marín F; de Oliveira Figueiredo MJ; de Simone G; Tzou WS; En Chiang C; Williams B
Editorial comment: LANCET. 2017;389(10085):2170-2172

Target blood pressure in patients at high cardiovascular risk.

Kahan T
Editorial comment: JOURNAL OF HYPERTENSION. 2017;35(6):1168-1169

Potential of folate supplementation to reduce mortality in hypertensive patients.

Kahan T; Spaak J
Review: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2017;49(1):46-53

Longitudinal study of vascular structure and function during normal pregnancy.

Iacobaeus C; Andolf E; Thorsell M; Bremme K; Jörneskog G; Östlund E; Kahan T
Review: EUROPEAN CARDIOLOGY. 2016;11(1):18-19

Guest Editorial Challenges in Resistant Hypertension.

Kahan T
Letter: HYPERTENSION RESEARCH. 2015;38(11):796-797

Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsia.

Kahan T; Bremme K; Östlund E
Editorial comment: JOURNAL OF HYPERTENSION. 2015;33(7):1371-1372

Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation.

Kahan T
Editorial comment: JOURNAL OF HUMAN HYPERTENSION. 2015;29(5):281-282

Renal nerve stimulation to predict responders to renal denervation.

Kahan T; Spaak J
Editorial comment: JOURNAL OF HYPERTENSION. 2015;33(4):690-692

The importance of left ventricular geometry in hypertensive heart disease.

Kahan T; Persson H
Editorial comment: LANCET. 2014;383(9932):1866-1868

Focus on blood pressure as a major risk factor.

Kahan T
Letter: JOURNAL OF HYPERTENSION. 2013;31(10):2103-2104

Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity.

Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P
Letter: JOURNAL OF HYPERTENSION. 2013;31(9):1917

Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply.

Kahan T; Schwieler JH; Wallén H; Nussberger J; Hjemdahl P
Review: EUROPEAN HEART JOURNAL. 2013;34(28):2159-2219

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Rydén L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Editorial comment: JOURNAL OF HYPERTENSION. 2012;30(4):685-687

The importance of myocardial fibrosis in hypertensive heart disease.

Kahan T
Other: LAKARTIDNINGEN. 2009;106(40):2550-2551

[Lower and lower cholesterol targets increase adverse effects].

Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B; Forfattarna utgör Läkemedelssakkunnigas (Läksak) e; Stockholms Iäns landsting
Review: JOURNAL OF WOMENS HEALTH. 2009;18(7):1049-1062

Treatment of mild to moderate hypertension by gender perspective: a systematic review.

Ljungman C; Mortensen L; Kahan T; Manhem K
Letter: JOURNAL OF HYPERTENSION. 2008;26(7):1497-1499

Left ventricular long-axis dysfunction in hypertensive patients -: Reply

Muller-Brunotte R; Kahan T
Editorial comment: HEART. 2008;94(2):e4

Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen.

Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B; ASCOT trial investigators
Editorial comment: DRUGS. 2006;66(7):970

Delapril/manidipine

Kahan T
Editorial comment: DRUGS. 2006;66(7):970-971

Delapril/manidipine: viewpoints.

Kahan T; Ambrosioni E
Other: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2005;9(4):276-279

Adenosine may not improve clinical outcomes for people with STEMI. Commentary.

Quintana M; Kahan T
Meeting abstract: AMERICAN JOURNAL OF HYPERTENSION. 2005;18(5):155A

Impaired night time reduction in blood pressure is associated with cardiac hypertrophy, increased natriuretic hormone levels and left ventricular systolic and diastolic dysfunction

Nyström FH; Malmqvist K; Lind L; Kahan T
Other: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2005;9(1):11-13

Atenolol is less effective than other antihypertensive drugs. Commentary 1.

Kahan T
Meeting abstract: VALUE IN HEALTH. 2004;7(6):694

Cost-effectiveness of reduction in cardiovascular outcomes with atorvastatin in patients with normal to mildly elevated cholesterol levels, treated for hypertension:: The ASCOT-LLA study

Lindgren P; Buxton MJ; Kahan T; Poulter N; Dahlöf B; Sever P; Wedel H; Jönsson B
Review: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2004;4(3):159-167

Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.

Quintana M; Kahan T; Hjemdahl P
Published conference paper: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2001;30 Suppl 1:S30-S34

A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden.

Hammar N; Alfredsson L; Rosén M; Spetz CL; Kahan T; Ysberg AS
Review: EUROPEAN JOURNAL OF HEART FAILURE. 2001;3(1):97-103

Epidemiology of heart failure in Sweden--a national survey.

Mejhert M; Persson H; Edner M; Kahan T
Published conference paper: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2001;(117):19-21

Pharmacoeconomic impact of HOPE.

Ostergren JB; Björholt I; Andersson F; Kahan T
Meeting abstract: JOURNAL OF HYPERTENSION. 2000;18:S165

ACE-gene polymorphism predicts blood pressure response to AT1-receptor antagonist treatment in hypertensive patients

Kurland L; Melhus H; Kahan T; Malmquist K; Öhman KP; Nyström F; Hägg A; Lind L
Published conference paper: JOURNAL OF HYPERTENSION, SUPPLEMENT. 1998;16(7):S23-S29

The importance of left ventricular hypertrophy in human hypertension.

Kahan T
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998;31:212A

Rate and extent of left ventricular hypertrophy regression: A comparison of angiotensin II blockade with irbesartan and beta-blockade

Kahan T; Malmqvist K; Edner M; Held C; Osbakken M
Visa fler

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI